• Home
  • Stock
  • Bal Pharma Fundamental Analysis
  • Bal Pharma Fundamental Analysis

Bal Pharma fundamental analysis

BALPHARMA

HealthcareSmall

75.75

0.23 (0.30%)
Last updated on 2 Dec, 2025 | 15:29 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bal Pharma Fundamentals

P/E Ratio

17.4

P/B Ratio

1.52

Div. Yield

1.61

Sector P/E

36.97

Sector P/B

0.87

Sec. Div. Yield

0.56

  • Bal Pharma Fundamentals is currently trading with a P/E Ratio of 17.4, compared to the sector average of 36.97. Its P/B Ratio stands at 1.52, while the sector’s is 0.87. In terms of returns, the stock offers a Dividend Yield of 1.61%, which is than the sector’s 0.56%.

Bal Pharma Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Poor

  • Management

    Poor

  • On its scorecard, Bal Pharma reflects: Price – Attractive, Growth – Average, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.